loadpatents
name:-0.034185886383057
name:-0.00048613548278809
name:-0.00046801567077637
Dubensky; Thomas W. JR. Patent Filings

Dubensky; Thomas W. JR.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dubensky; Thomas W. JR..The latest application filed is for "listeria-induced immunorecruitment and activation, and methods of use thereof".

Company Profile
0.0.20
  • Dubensky; Thomas W. JR. - Piedmont CA
  • Dubensky, Thomas W. JR. - Rancho Sante Fe CA
  • Dubensky, Thomas W. JR. - Del Mar CA
  • Dubensky, Thomas W. JR. - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Listeria-induced immunorecruitment and activation, and methods of use thereof
App 20070190029 - Pardoll; Drew M. ;   et al.
2007-08-16
Modified Bacillus anthracis, vaccine compositions and methods of use thereof
App 20070031457 - Dubensky; Thomas W. JR. ;   et al.
2007-02-08
Listeria-based EphA2 vaccines
App 20050281783 - Kinch, Michael S. ;   et al.
2005-12-22
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
App 20050249748 - Dubensky, Thomas W. JR. ;   et al.
2005-11-10
Method for the purification of alphavirus replicon particles
App 20050112752 - Polo, John M. ;   et al.
2005-05-26
Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof
App 20040228877 - Dubensky, Thomas W. JR. ;   et al.
2004-11-18
Modified free-living microbes, vaccine compositions and methods of use thereof
App 20040197343 - Dubensky, Thomas W. JR. ;   et al.
2004-10-07
Eukaryotic layered vector initiation systems
App 20040029278 - Dubensky, Thomas W. JR. ;   et al.
2004-02-12
Eukaryotic layered vector initiation systems
App 20030232035 - Dubensky, Thomas W. JR. ;   et al.
2003-12-18
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
App 20030232058 - Dubensky, Thomas W. JR. ;   et al.
2003-12-18
Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
App 20030223963 - Davidson, Beverly ;   et al.
2003-12-04
Alphavirus-based vectors for persistent infection
App 20030170871 - Dubensky, Thomas W. JR. ;   et al.
2003-09-11
Feline immunodeficiency virus gene therapy vectors
App 20030104611 - Johnston, Julie C. ;   et al.
2003-06-05
Methods of suppressing immune response by gene therapy
App 20030091546 - Barber, Jack R. ;   et al.
2003-05-15
Nucleic acid mucosal immunization
App 20030021766 - Vajdy, Michael ;   et al.
2003-01-30
Functional lentiviral vector from an MLV-based backbone
App 20030003565 - Dubensky, Thomas W. JR. ;   et al.
2003-01-02
Feline immunodeficiency virus gene therapy vectors
App 20020068354 - Johnston, Julie C. ;   et al.
2002-06-06
Feline Immunodeficiency Virus Gene Therapy Vectors
App 20020048805 - JOHNSTON, JULIE C. ;   et al.
2002-04-25
Methods of transducing neural cells using lentivirus vectors
App 20020037281 - Davidson, Beverly L. ;   et al.
2002-03-28
Method for the purification of alphavirus replicon particles
App 20020015945 - Polo, John M. ;   et al.
2002-02-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed